Consumer Rights Act 2015 (c. 15)

SCHEDULES

SCHEDULE 5 U.K. Investigatory powers etc.

Modifications etc. (not altering text)

C1 Sch. 5 applied (with modifications) (8.12.2016) by The Electromagnetic Compatibility Regulations 2016 (S.I. 2016/1091), reg. 1, Sch. 7 para. 3 (with regs. 74, 75(5))

C2 Sch. 5 applied (with modifications) (26.12.2017) by The Radio Equipment Regulations 2017 (S.I. 2017/1206), reg. 1, Sch. 10 para. 3 (with regs. 3-5, 77)

C3 Sch. 5: power to amend conferred (1.7.2022) by Health and Care Act 2022 (c. 31), ss. 180(3)(a), 186(6); S.I. 2022/734, reg. 2(a), Sch. (with regs. 13, 29, 30)

PART 4 U.K. Further powers exercisable by domestic enforcers and [F1 Schedule 13 enforcers]

Textual Amendments

F1 Words in Sch. 5 Pt. 4 heading substituted (31.12.2020) by The Consumer Protection (Enforcement) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/203), regs. 1, 4(7) (with reg. 9) (as amended by S.I. 2020/1347, regs. 1(3), 3(8)); 2020 c. 1, Sch. 5 para. 1(1)

Power to decommission or switch off fixed installations U.K.

[F2 30A (1) The power in sub-paragraph (2) is available to an officer of a domestic enforcer acting [F3 pursuant to— U.K.

(a) the duty in regulation 61(1A) or (1B) of the Medical Devices Regulations 2002 (S.I. 2002/618),

(b) a duty in regulations made under section 15(1) of the Medicines and Medical Devices Act 2021, or

(c) the duty in regulation 26 of the Medical Devices (Northern Ireland Protocol) Regulations 2021.]

(2) The officer may decommission or switch off any [F4 relevant medical device] which is installed at a given location.

[F5 (3) In sub-paragraph (2), “relevant medical device” means—

(a) where a domestic enforcer is acting pursuant to a duty mentioned in sub-paragraph (1)(a) or (b), any medical device to which the Medical Devices Regulations 2002 apply;

(b) where a domestic enforcer is acting pursuant to the duty mentioned in sub-paragraph (1)(c), any medical device to which Regulation (EU) 2017/745 on medical devices [F6 or Regulation (EU) 2017/746 on in vitro diagnostic medical devices] applies.]]

Textual Amendments

F2 Sch. 5 para. 30A inserted (26.5.2021) by Medicines and Medical Devices Act 2021 (c. 3), ss. 41(2)(d), 50(3); S.I. 2021/610, reg. 2(c) (with reg. 3)

F3 Words in Sch. 5 para. 30A(1) substituted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 27(5)(a)

F4 Words in Sch. 5 para. 30A(2) substituted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 27(5)(b)

F5 Sch. 5 para. 30A(3) inserted (27.7.2021) by The Medical Devices (Northern Ireland Protocol) Regulations 2021 (S.I. 2021/905), regs. 1(2), 27(5)(c)

F6 Words in Sch. 5 para. 30A(3)(b) inserted (21.3.2024) by The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024 (S.I. 2024/221), regs. 1(2), 4(c)